Risk factor awareness and secondary prevention of coronary artery disease: Are we doing enough?

Interactive Cardiovascular and Thoracic Surgery

Volumn 5, Issue 3, 2006, Pages 268-271

  Karthik, Shishir ^a   Tahir, Nasim ^a   Thakur, Bibhuti ^a   Nair, Unnikrishnan ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Coronary artery disease; Risk factor; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AWARENESS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FAMILY HISTORY; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

EID: 33744497296     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2005.120956     Document Type: Conference Paper

References (14)

1. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. European Heart Journal 2002;23:1738-1752.
2. Ferguson T, Hammill B, Peterson E, DeLong ER, Grover FL. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures 1990-1999: a report from the STS national database committee and the Duke clinical research institute. Society of Thoracic Surgeons. Ann Thorac Surg 2002;73:480-489.
3. Greenland P, Gidding SS, Tracy RP. Commentary: lifelong prevention of atherosclerosis: the critical importance of major risk factor exposures. Int J Epidemiol 2002 Dec;31:1129-1134.
4. Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists? Int J Epidemiol 2002 Dec;31:1117-1122.
5. Pearson T, Rapaport E, Criqui M, Furberg C, Fuster V, Hiratzka L, Little W, Ockene I, Williams G. Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American heart association writing group. Circulation 1994;90:3125-3133.
6. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
7. Foody JM, Ferdinand FD, Galusha D, Rathore SS, Masoudi FA, Havranek EP, Nilasena D, Radford MJ, Krumholz HM. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation 2003 Sep 9;108:II24-II28.
8. Herlitz J. Secondary prevention after coronary artery bypass grafting - what do we know? Scand Cardiovasc J 2004 May;38:69-74.
9. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, Gott JP, Herrmann HC, Marlow RA, Nugent W, O'Connor GT, Orszulak TA, Rieselbach RE, Winters WL, Yusuf S, Gibbons RJ, Alpert JS, Garson A Jr, Gregoratos G, Russell RO, Ryan TJ, Smith SC Jr. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American college of cardiology/American heart association task force on practice guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 1999 Sep 28;100:1464-1480.
10. Denton TA, Fonarow GC, LaBrseh KA, Trento A. Secondary prevention after coronary bypass: the American heart association 'Get with the guidelines' program. Ann Thorac Surg 2003 Mar;75:758-760.
11. Bowker TJ, Clayton TC, Ingham J, McLennan NR, Hobson HL, Pyke SD, Schofield B, Wood DA. British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 1996 Apr;75:334-342.
12. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol 1997 Oct 30;80:45H-52H.
13. Abookire SA, Karson SA, Fiskio J, Bates DW. Use and monitoring of 'statin' lipid-lowering drugs compared with guidelines. Arch Intern Med 2001 Jan 8;161:53-58.
14. Irving JR, Oram SH, Boyd J, Rutledge P, McRae F, Bloomfield P. Ten year audit of secondary prevention in coronary bypass patients. Br Med J 2000 Jul 1;321:22-23.